Introducing TurboMice™ - a breakthrough innovation from Guangzhou MingCeler Biotech Co., Ltd., offering high-quality Cd34 Humanized Mice. With our deep expertise in the field of preclinical research, we are proud to present this cutting-edge product designed to revolutionize the way researchers study hematopoiesis, immune development, and cancer biology. TurboMice™, our Cd34 Humanized Mice, have been developed using advanced gene-editing technologies and are characterized by their superior engraftment efficiency and robust multilineage hematopoiesis. These humanized mice provide an ideal in vivo model for assessing the efficacy and safety of therapeutic interventions in various disease areas, including hematological malignancies, autoimmune disorders, and infectious diseases. At Guangzhou MingCeler Biotech Co., Ltd., quality is our utmost priority. We meticulously select and validate our Cd34 Humanized Mice to ensure consistent and reliable research outcomes. Coupled with our comprehensive technical support and dedicated customer service, we strive to provide scientists and pharmaceutical companies with an exceptional experience throughout their research journey. Unlock new possibilities in your research with TurboMice™ - the ultimate tool for unraveling the complexities of human hematopoiesis and accelerating medical advancements. Trust Guangzhou MingCeler Biotech Co., Ltd. as your partner for high-quality products and services in the field of preclinical research.